Acupuncture for children and teens with chronic inflammatory bowel diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of acupuncture as a complementary treatment for children and adolescents suffering from chronic inflammatory bowel diseases (CIBD), such as Morbus Crohn and Ulcerative Colitis. It aims to assess the impact of acupuncture on disease activity, chronic pain, quality of life, and inflammation levels using validated measurement indices. Participants will receive either acupuncture or placebo-acupuncture while maintaining stable pharmacological treatment. The study seeks to provide evidence for the efficacy of acupuncture in managing pediatric CIBD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* mild/moderate CIBD
* stable pharmacological treatment at least for 8 weeks

Exclusion Criteria:

* complementary alternative medicine

Where it's running

• Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna
  Vienna, Austria Recruiting

Study contacts

• Principal investigator: Gisela Scharbert, MD — MedUniVienna
• Study coordinator: Gisela Scharbert, MD, PhD
• Email: gisela.scharbert@meduniwien.ac.at
• Phone: 01 40400 41000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Magnesium status in people with IBD, ileostomy, or bile acid diarrhea

  This will test different ways to check magnesium in adults with Crohn's disease, ulcerative colitis, ileostomies, or bile acid diarrhea to see which method best finds deficiency.

  Recruiting University of Aarhus · Aarhus N · NCT07338565

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Aletekitug safety study in moderate to severe ulcerative colitis

  This sub-study tests whether aletekitug, an anti-IL-18 medication, is safe and tolerable for people with moderately to severely active ulcerative colitis.

  Recruiting Phase 1 GlaxoSmithKline · Oxford · NCT07747480

• Treatment study to test multiple interventions for moderate to severe ulcerative colitis

  This study tests whether a single master protocol can safely test the anti-IL-18 treatment Aletekitug (GSK1070806) in adults with moderate to severe ulcerative colitis to see if it is tolerable and potentially beneficial.

  Recruiting Phase 1 GlaxoSmithKline · Oxford · NCT07747467

• Characterization of Colorectal Dysplastic Lesions and Changes in Risk in IBD Patients

  This study tests how colorectal dysplastic lesions in adults with Crohn disease or ulcerative colitis change over time to help tailor screening and treatment.

  Recruiting at 2 sites Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Amiens and 1 other locations · NCT07719426

• Resting energy use in kids with inflammatory bowel disease

  This multicenter study will test the resting energy expenditure of children aged 6–17 with new IBD diagnoses to see how it relates to disease activity and treatment.

  Recruiting Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Alessandria, Piedmont · NCT07670975

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.